NCT00002326已完成1 期
A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of Combination Zidovudine (AZT) and 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA; Adefovir) Treatment in HIV-Infected Patients
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
研究概览
简要总结
To study the safety, tolerance, pharmacokinetics, and anti-HIV effects of combination zidovudine (AZT) and PMEA (adefovir) therapy.
详细描述
Patients receive AZT daily and intravenous PMEA three times weekly for 4 weeks. An MTD will be defined for this regimen.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV DrugsHIV InfectionsNCT00001067National Institute of Allergy and Infectious Diseases (NIAID)105
已完成
1 期
A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV DiseaseHIV InfectionsNCT00000814National Institute of Allergy and Infectious Diseases (NIAID)390
已完成
1 期
A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV DiseaseHIV InfectionsNCT00000696National Institute of Allergy and Infectious Diseases (NIAID)48
已完成
不适用
A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDSHIV InfectionsNCT00002285Glaxo Wellcome
已完成
1 期
The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected PatientsHIV InfectionsNCT00002346Gilead Sciences36